Introduction
============

Patients with borderline personality disorder (BPD) suffer from difficulties in emotion regulation which include affective instability, impulsivity, fear of abandonment, eruptions of rage, feelings of emptiness, unstable interpersonal relationships, chronic dysphoria or depression, as well as heightened risk-taking behaviors.[@b1-ppa-10-1421]--[@b3-ppa-10-1421] These emotional disturbances occur in association with negative thoughts about oneself and interpersonal poor functioning.[@b3-ppa-10-1421],[@b4-ppa-10-1421] The impairment resulting from this condition and suicidal risk are mostly seen in the young-adult age and progressively decline with advancing age.[@b3-ppa-10-1421] The relationships of individuals with BPD may be chaotic, intense, and marked with difficulties.[@b3-ppa-10-1421],[@b5-ppa-10-1421] The prevalence of BPD in the general population, as shown by current community studies, is expected to be 0.5%--2.7% (median =0.7%).[@b6-ppa-10-1421],[@b7-ppa-10-1421] There are higher frequencies of BPD among patients in contact with mental health services, mainly inpatient departments, where up to one-fifth of patients may suffer from this disorder.[@b8-ppa-10-1421] People meeting diagnostic criteria for BPD pose a great challenge to therapists. They are frequently refractory, unpredictable, and become too close or too distant in the therapeutic relationship.[@b9-ppa-10-1421] They display high affective instability, are prone toward impulsive, self-mutilating, aggressive, and suicidal behavior, unstable identity, dissociation, conflicting interpersonal relations, chaotic lifestyle, high comorbidity levels, and low treatment efficacy.[@b10-ppa-10-1421]--[@b12-ppa-10-1421] They provoke robust countertransferences in the therapist, who may become too rejecting or too seductive, or probably could fluctuate more among the extremes.[@b6-ppa-10-1421],[@b13-ppa-10-1421]--[@b15-ppa-10-1421] Treatment possibilities include pharmacotherapy (especially mood stabilizers, atypical antipsychotics, or antidepressants) and psychotherapeutic interventions that are focused on affective dysregulation, increasing distress tolerance, changing distorted schemas and beliefs, and introducing new communication, and social and relationship problem-solving skills, especially in Dialectical Behaviour Therapy, Cognitive Therapy, and Schema Therapy or through intensive work with transference or mentalization in psychodynamic approaches like Transference Focus Therapy or Mentalization Therapy.[@b14-ppa-10-1421],[@b16-ppa-10-1421]--[@b21-ppa-10-1421]

Recently, as a result of an augmented focus on patients' experiences and their needs, the idea of the quality of life (QoL) has been taken into account in the investigation of psychiatric conditions, such as BPD.[@b22-ppa-10-1421] The dimension of the QoL gives additional information that supports a multidimensional view in research and treatment of BPD.[@b22-ppa-10-1421] QoL is gaining more significance as an important instrument to measure outcome of treatment interventions. Research data has established that QoL is strictly reduced in BPD.[@b22-ppa-10-1421],[@b23-ppa-10-1421] The fundamental problems of BPD include dissatisfaction, negative schemas about the person and others, and instability, which can significantly change some answers in a short time frame. BPD strongly impairs QoL across psychic, social, and physical domains.[@b22-ppa-10-1421] In a study by Perseius et al[@b24-ppa-10-1421] which compared the QoL between females with BPD and normal population, the authors found that women with BPD were significantly impaired in all areas, including emotional, cognitive, physical, and sexual functioning. Relations with their family and partner were also found to be impaired. Two studies have shown that the burden of BPD on individuals with different personality disorders is severe, and their QoL is manifestly impaired.[@b25-ppa-10-1421],[@b26-ppa-10-1421] Nevertheless, the studies focused only on particular groups of patients, that is, people with the borderline disorder who do not function well. They did not capture satisfied or well-functioning individuals, and may reinforce the conclusion that people who have BPD also have reduced QoL. Following our studies of the QoL and related factors in schizophrenia[@b27-ppa-10-1421]--[@b29-ppa-10-1421] and bipolar disorder,[@b30-ppa-10-1421] and on the basis of the outcomes in the literature,[@b22-ppa-10-1421] we decided to study the factors, which proved to be related to the QoL, like the severity of anxiety and depression, the degree of dissociation, unemployment, partner or marital problems, and the early onset of psychopathology.

One of the most important factors which could impair the QoL is functional impairment. Persons diagnosed with BPD are predisposed to have a substantial degree of functional impairment through a variety of social and occupational domains, including trouble with finding and maintaining adequate work, housing, or relations.[@b31-ppa-10-1421] BPD patients have poor social functioning; they are often socially isolated and unemployed or on long-term sick dispensation.[@b32-ppa-10-1421] Many patients with BPD do not finish their education or complete it at a minimal level. Similarly, many of them have a career which does not correspond with their capabilities, or they have no job at all. BPD patients often participate in problematic relationships and practice problematic parenting.[@b3-ppa-10-1421],[@b33-ppa-10-1421]--[@b35-ppa-10-1421]

Other factors which could influence the QoL in BPD are the severity of psychopathology and frequent comorbidities with other psychiatric disorders.[@b22-ppa-10-1421] The severity of the disorder is often increased in the case of comorbidities.[@b12-ppa-10-1421],[@b36-ppa-10-1421] Depression, anxiety, self-injury, suicide attempts, and substance abuse are frequent problems in BPD.[@b37-ppa-10-1421]--[@b39-ppa-10-1421] People with BPD are associated with higher rates of deliberate self-harm and a high rate of completed suicide which is 50 times more than in the general population; \~8%--10% of BPD patients finish their lives prematurely due to suicide.[@b33-ppa-10-1421] Several studies have found that BPD patients are at heightened risk of developing depression and anxiety disorder, as well as frequent multiple comorbidities.[@b12-ppa-10-1421],[@b39-ppa-10-1421]--[@b44-ppa-10-1421] In a US study on BPD, the results robustly predicted the persistence of four anxiety disorders (generalized anxiety disorder (GAD), social and specific phobias, and panic disorder) over 3 years.[@b32-ppa-10-1421] BPD negatively affects the course of social phobia, GAD, and posttraumatic stress disorder (PTSD).[@b43-ppa-10-1421],[@b45-ppa-10-1421] Dissimilarly, the anxiety disorders, aside from PTSD, have a minimal effect on BPD course.[@b43-ppa-10-1421]

Job environment can be one of the areas where patients with BPD struggle for maintaining their identity.[@b46-ppa-10-1421]--[@b49-ppa-10-1421] Conflicts with boss and colleagues are frequent; individuals with BPD mostly fight against assumed injustice and nepotism and accuse the others of incompetence, lack of diligence, and gaining benefits from their bosses. Occupational patterns are characterized by instability, intense preoccupation, the subsequent loss of interest in the job, lack of job satisfaction, and problems in relationships.[@b48-ppa-10-1421],[@b49-ppa-10-1421] Later in life, most of them achieve greater stability in social and work functioning.[@b47-ppa-10-1421]

Numerous investigations established the close link between BPD and dissociation.[@b50-ppa-10-1421]--[@b53-ppa-10-1421] Chronic and complex dissociative symptoms are common.[@b51-ppa-10-1421],[@b52-ppa-10-1421],[@b54-ppa-10-1421]--[@b56-ppa-10-1421] Dissociation is understood as a coping strategy to deal with tough, stressful circumstances, and with hurtful trauma experiences.[@b54-ppa-10-1421],[@b57-ppa-10-1421],[@b58-ppa-10-1421] Dissociative processes are usually recognized as the consequence of childhood trauma, although there are reports that genetic impacts are also significant.[@b59-ppa-10-1421] These processes result in the compartmentalization of thoughts, sensations, emotions, and memories that are too overwhelming for patients' consciousness to integrate. These processes may be maladaptive because it leads to an inaccurate understanding of reality, memory deficits, emotional freezing, feelings of disconnectedness with reality, and out-of-body experiences. Perhaps, these processes could explain the association between dissociation and many disorders including BPD.[@b3-ppa-10-1421],[@b50-ppa-10-1421],[@b51-ppa-10-1421],[@b60-ppa-10-1421]--[@b62-ppa-10-1421] Rather than this explanation, the vast majority of studies have focused on environmental antecedents of dissociative dispositions, notably childhood trauma. It has been fairly well established that exposure to childhood abuse facilitates the development of dissociative defense mechanisms.[@b57-ppa-10-1421],[@b63-ppa-10-1421] Childhood trauma has been connected with dissociation, and people exposed to childhood abuse display a greater degree of anxiety.[@b64-ppa-10-1421]--[@b66-ppa-10-1421] There is a lack of studies about the QoL and dissociation in BPD, but according to our previous study, a higher level of dissociation could be linked to the lower level of the QoL in bipolar disorder patients.[@b10-ppa-10-1421] Also, a review by Jones et al[@b67-ppa-10-1421] in adults with psychogenic nonepileptic seizures showed the association between health-related QoL and dissociation.

The aim of this study is to examine the QoL of borderline patients comorbid with anxiety spectrum disorders and compare this with the QoL of healthy controls. The second aim was to study if dissociation and demographic or clinical characteristics of the patients can influence QoL experienced by this population.

Methods
=======

Consecutively hospitalized BPD patients with comorbid anxiety disorder were included in the study. All patients were treated at the same psychotherapeutic department for 6 weeks. Diagnoses were assessed and confirmed by two licensed psychiatrists, independently. The International Classification of Diseases[@b68-ppa-10-1421] was used as a primary diagnostic tool. [Table 1](#t1-ppa-10-1421){ref-type="table"} presents the inclusion and exclusion criteria.

Brief description of the assessment tools
-----------------------------------------

### The Quality of Life Satisfaction and Enjoyment

The Quality of Life Satisfaction and Enjoyment Questionnaire (Q-LES-Q)[@b69-ppa-10-1421] is a questionnaire with 93 questions, divided into eight domains, answered mainly using a five-point Likert-type scale. It is self-completed, possibly with the help of an investigator. It takes from 20 to 30 minutes to complete, according to the health status of the patient. Patients complete the areas like physical health, feelings, leisure, social relations, and a summary of the QoL experienced during the past week. Müllerova et al[@b70-ppa-10-1421] validated the Czech version of the Q-LES-Q. The analyses indicated the high internal consistency (Cronbach alpha =0.8--0.9) and proved the stability of answers over time (test--retest). The particular Q-LES-Q tests correlated highly (*P*\>0.01) with the Hamilton Depression Rating Scale, Clinical Global Impression (CGI), and both BDI and BAI questionnaires.

### Dissociative Experiences Scale

The Dissociative Experiences Scale (DES)[@b71-ppa-10-1421],[@b72-ppa-10-1421] is a self-administered 28-item inventory of psychological dissociation, where patients rate on a visual analog scale as to how frequently they experience the dissociative symptoms (in the percentage of time). The Czech version of the scale is equal to the original version regarding its test--retest reliability, validity, and factor structure.[@b73-ppa-10-1421] Pathological DES was assessed by a Dissociative Experiences Scale Taxon (DES-T) based on the items of DES numbers 3, 5, 7, 8, 12, 13, 22, and 27.[@b74-ppa-10-1421],[@b75-ppa-10-1421] These items measure identity alteration, depersonalization, derealization, discontinuation of awareness, dissociative amnesia, and auditory hallucinations. Cronbach alpha of DES was excellent (*α*=0.96).[@b74-ppa-10-1421],[@b76-ppa-10-1421] The Czech translation showed psychometric properties equal to the original version of the scale.[@b77-ppa-10-1421]

### Beck Depression Inventory

The Beck Depression Inventory (BDI)-II[@b78-ppa-10-1421] scale includes 21 items covering main depressive symptoms. The patient rates the severity of each perceived symptom experienced during the last week. Internal consistency of the scale is higher in psychiatric population (*α*=0.86) than in general population (*α*=0.81).[@b79-ppa-10-1421] The Czech version was validated and published by Preiss and Vacir; the Cronbach alpha reached 0.89.[@b80-ppa-10-1421]

### Beck Anxiety Inventory

The Beck Anxiety Inventory (BAI)[@b81-ppa-10-1421] scale is based on 21 items -- anxiety symptoms -- rated on a four-point Likert scale. The patient indicates perceived symptoms and their severity during the last week. The Cronbach alpha for the Czech version of the scale is 0.92.[@b82-ppa-10-1421]

### Clinical Global Impression

The CGI[@b83-ppa-10-1421] scale is used for global assessment of the severity of psychopathology. The first evaluation is performed by the patient's psychologist or psychiatrist using the objective form of the scale evaluating the severity of the disorder (objCGI-S). The patient also assesses himself/herself by the subjective version (subjCGI-S), which includes seven levels of severity of the psychopathology. The intra-class correlations lie in the interval 0.88--0.92.[@b84-ppa-10-1421]

### Demographic questionnaire

The demographic questionnaire contains basic information such as sex, age, education, employment of pension status, age of disease onset, number of hospitalizations, time since the last hospitalization, duration of attendance at the outpatient clinic, number of visited psychiatrists, current medication, and discontinuation of drugs in the past (recommended by a psychiatrist or arbitrarily).

### Sheehan Disability Scale

The Sheehan Disability Scale (SDS)[@b85-ppa-10-1421]--[@b87-ppa-10-1421] is a patient-rated, analog measure of functional disability in work, social, and family life. The patient rates the extent to which these areas of life are impaired on a ten-point visual scale.[@b88-ppa-10-1421]

### Sheehan Anxiety Scale

The Sheehan Anxiety Scale (SAS)[@b86-ppa-10-1421],[@b89-ppa-10-1421],[@b90-ppa-10-1421] (Sheehan Patient-Rated Anxiety Scale) is a 35-question multiple-choice self- inventory used to measure the severity of anxious symptoms.

Treatments
----------

The mean duration of the outpatient treatments before admission to the hospital was 7.83±7.20 years. At the time of the beginning of hospitalization, 82 patients were treated with psychopharmacies using usual dosages of antidepressants, or mood stabilizers, or low dosages of antipsychotics. Average dosages of antidepressants according to paroxetine index were 39.68±23.31 mg per day (n=71), antipsychotics according to risperidone index were 1.68±1.63 (n=35) mg per day, anti-epileptics lamotrigine were 179.40±90.67 mg per day (n=17) or valproate were 1,067.00±394.10 mg per day (n=18), and anxiolytics according to diazepam index were 12.00±11.65 mg per day (n=28). Two patients also used lithium at an average dosage of 750.00±212.10 mg per day. Ten patients were medication-free (10.9%), 25 patients used monotherapy (27.2%; 19 antidepressants, six antiepileptics), 20 patients two drugs (21.8%; 12 patients combination of antidepressant and antipsychotic, five patients combination of antiepileptic and antidepressant, three patients combination of antidepressant and anxiolytic), 33 patients three or more psychotropic drugs (35.9%), and six patients four or more drugs in combination (6.5%). Sixty-two (67.4%) patients had undergone formal psychotherapy on an outpatient basis before the admission to the hospital. The types of previous psychotherapy were wide (gestalt therapy, psychodynamic group psychotherapy, existential psychotherapy, and supportive psychotherapy), but no empirically supported programs for BPD were used.

Statistical analysis and ethics approval
----------------------------------------

The statistical programs Prism3 (GraphPad Software, Inc., La Jolla, CA, USA) and SPSS 17 (SPSS Inc., Chicago, IL, USA) were used for statistics. Demographic data and scores of the specific questionnaires were assessed using descriptive statistics. Means, medians, standard deviations, and distribution of data were defined. The Shapiro--Wilk *W* test was used to determine the Gaussian distribution of the demographic and QoL variables. The Student's *t*-tests or the Mann--Whitney tests were used for comparison of the means. The relationships between individual categories were analyzed using correlation coefficients and linear regression. The Fisher test or chi-square test was used to verify the connection between alternative variables (sex, marital status, discontinuation of the medication). The interactions between variables with normal distribution were calculated using Pearson correlation, while Spearman rank correlation was used for variables with non-normal distribution. Backward stepwise regressions were applied to analyze the significance of the correlations of the particular factors. Backward elimination, which we used, involved starting with all variables which correlated with the particular domain and deleting the variable that developed the statistical power of the model the most, and repeating the procedure until no additional upgrading was possible. The 5% level of statistical significance was considered to be acceptable for all statistical tests. The ethics committee of University Hospital Olomouc approved the study. The investigation was conducted following the guidelines of the latest version of the Declaration of Helsinki and standards of Good Clinical Practice.[@b91-ppa-10-1421] Signed informed consent was obtained from all patients.

Results
=======

Sample description
------------------

There were 515 patients with anxiety spectrum disorder admitted during the period from January 2010 to December 2014 to the psychotherapeutic department. Of them, 114 (22.1% of total) were diagnosed with BPD with comorbid anxiety spectrum disorder. Twenty-two of them (19.3%) refused to collaborate in the study. There were data from 92 patients used in the study. Forty healthy controls were recruited through advertisement ([Table 2](#t2-ppa-10-1421){ref-type="table"}).

Comparison of QoL in BPD patients and healthy controls
------------------------------------------------------

The groups of patients and controls did not differ in mean age and the level of education, but there was a significant difference in marital status and occupation ([Table 2](#t2-ppa-10-1421){ref-type="table"}). The QoL was statistically significantly impaired in all domains (physical health, feelings, work, household, school, leisure time, social activities, and QoL in general) measured by Q-LES-Q in both patients and controls ([Table 1](#t1-ppa-10-1421){ref-type="table"}).

Comorbidity
-----------

BPD comorbidity with other anxiety disorders on Axis I (according to the International Classification of Diseases, Tenth Revision) was identified. The percentage of comorbidities is presented in [Table 3](#t3-ppa-10-1421){ref-type="table"}.

Comparisons of the subgroups of patients with four different comorbid anxiety disorders (panic disorder/agoraphobia, social phobia, GAD, and adjustment disorder) were used for domains of physical health, feelings, household, leisure, social activities, and general, because there were enough responders, but not for domains of work and school/study, because there were not enough responders in the group of patients. Obsessive--compulsive disorder, PTSD, and somatoform disorder/dissociative disorder were collected in one subgroup named "others". The diagnostic subgroups did not statistically significantly differ in any of calculated Q-LES-Q domains ([Table 4](#t4-ppa-10-1421){ref-type="table"}).

There were no statistically significant differences in the level of dissociation (DES) or pathological dissociation (DES-T) between comorbid diagnostic subgroups. There were no statistically significant differences in the degree of depression (BDI) and the level of general anxiety (BAI) between comorbid diagnostic subgroups, except the difference between comorbid panic disorder/agoraphobia and social phobia in BAI (Bonferroni's multiple comparison test). No statistically significant differences were seen between diagnostic comorbidity subgroups in anxiety symptoms measured by SAS, and global clinical severity measured by a physician using objCGI-S and by patients using subjCGI-S ([Table 5](#t5-ppa-10-1421){ref-type="table"}). The comorbidity subgroups did not statistically differ in disabilities in work/school area (SDS-work/school), social life (SDS-social life), and family life (SDS-family).

Relationship between the QoL in BPD and demographic and clinical variables
--------------------------------------------------------------------------

The overall QoL negatively correlated highly with the severity of the disorder at the start of treatment, measured by CGI, by both psychiatrist and patient.

There was also a significant negative correlation between the overall QoL and level of anxiety measured by BAI and level of depression measured by BDI.

The domains of Q-LES-Q did not correlate significantly with age, length of the disorder, and age of the disorder onset except the negative correlation between the physical health domain of Q-LES-Q and age of the disorder onset ([Table 6](#t6-ppa-10-1421){ref-type="table"}). From the psychopathological measures, the level of dissociation measured by DES and DES-T statistically negatively correlated with the domain leisure time; for example, the higher level of dissociation was linked to the lower level of QoL in leisure time. The subjective level of depression measured by BDI correlated with all Q-LES-Q domains. It was different for scales that measured anxiety level (BAI and SAS), since both significantly negatively correlated with domains of physical health, household, leisure time, and QoL in general but not with feelings, work, and social activities domains. The same result was seen for the correlation of subjCGI-S ([Table 6](#t6-ppa-10-1421){ref-type="table"}). ObjCGI-S did not statistically significantly correlate with two domains, feelings and work, but with all other domains, there were highly significant negative correlations; a higher level of global clinical severity was associated with the lower level of QoL in most of the domains. The subjective level of handicaps measured by SDS showed statistically negative correlation of subscale work with domains of physical health and leisure time, and the negative correlation of subscale social life and subscale family with all domains of Q-LES-Q ([Table 6](#t6-ppa-10-1421){ref-type="table"}).

There were only two statistically significant negative correlations between Q-LES-Q domains and medication, both with a dosage of an antidepressant, which negatively correlated with leisure time and QoL in general. There was no significant correlation between dosages of antipsychotics and anxiolytics ([Table 6](#t6-ppa-10-1421){ref-type="table"}).

Regression analysis
-------------------

Because of the numerous aspects significantly related to the Q-LES-Q domains, a multiple regression analysis was performed (backward stepwise regression) to identify the most important factors connected with each domain of the Q-LES-Q in patients with BPD. The dependent variable was the domains of the Q-LES-Q questionnaire. Demographic variables and scores of the questionnaires were used as the independent variables, which correlated with each domain ([Table 7](#t7-ppa-10-1421){ref-type="table"}).

In the physical health domain, backward stepwise regression contained five steps, and the initial nine parameters narrowed to four independent, of which three explained that this domain was statistically significant with a negative sign. These were the age of onset of the disorders, severity of depressive symptoms assessed by BDI, and the rate of disability at work in subscale SDS-work. This means that the lower age of onset of disorders, a lower level of depression, and lower subjective evaluation of disability in the working area are connected with the higher QoL in the domain of physical health ([Table 7](#t7-ppa-10-1421){ref-type="table"}).

In the domain of feelings, backward stepwise regression reduced from three to two independent factors already in the second step. Only one was statistically significant with a negative sign; it was an assessment of the disability in family functioning (SDS-family). If the patients evaluated their disability in family functioning as lower, they would assess their QoL in the domain of feelings as better.

In the domain of work, which was completed only by 32 participants (having a job), the backward stepwise regression dropped during third step to a single factor, which was BDI total score. The standardized *β* coefficient was negative for this factor. This means that the patients who have fewer symptoms of depression also have the higher QoL in the domain of work.

The domain of household initially significantly correlated with a total of nine factors including the dose of antidepressant medication. During the three steps, three most important independent factors were taken: rates of depression, the rate of disability in the family, and the level of social impairment, which was significantly related to the functioning of the household domain. All the three factors had a negative standardized *β* coefficient. This means that the lower the level of depression, disability in the family, and social impairment, the higher the QoL in the family.

The domain leisure correlated with ten clinical factors. During the eight steps, six factors gradually phased out, leaving only the rate of dissociation evaluated by DES and the assessment of the disability in social functioning, both with a negative sign in a standardized *β* coefficient. This means that the lower the rate of dissociation and less perceived the handicap in social functioning, the higher the QoL in the domain of leisure.

The domain social activities correlated with three factors at the start. During the second step, two independent factors remained, which were significantly associated with this domain. They were the social adjustment and the degree of depression. Both factors had a negative sign of a standardized *β* coefficient.

The domain of general correlated with the four factors at the start. After three steps of backward regression analysis, the factors were reduced to two independent factors. They were social disability and severity of depression; both had a negative sign of the standardized coefficient *β*. This means that the lower the severity of depression and social impairment, the higher the general subjective QoL ([Table 7](#t7-ppa-10-1421){ref-type="table"}).

Discussion
==========

In our study, patients and healthy controls were well matched for age, sex, and education, showing no significant distinctions. Differences in marital status were referred to previous papers.[@b92-ppa-10-1421] Also in our sample of patients, it was more common to be a single or divorced person compared to controls. As we expected, patients scored significantly more items in BAI and BDI than controls. High level of depression in BPD patients is frequent also in other studies,[@b93-ppa-10-1421] and the comorbidity with depressive disorders is also common.[@b39-ppa-10-1421],[@b94-ppa-10-1421] The higher level of anxiety measured by BAI is predictable in patients with comorbid anxiety disorders. The relatively high match between subjCGI and objCGI could be surprising in borderline patients, who often say that they are healthy and have not been really ill patients. The harmony between the objective and subjective evaluation of the severity of the disorder contrasts with the common stigmatizing belief of clinicians that patients with BPD are manipulative and aggravate their problems.[@b9-ppa-10-1421],[@b95-ppa-10-1421]

The main aim of our study was to investigate the QoL in BPD comorbid with anxiety disorders and compare it with the QoL of healthy controls. BPD patients experienced statistically significantly impaired QoL compared with the healthy controls ([Figure 1](#f1-ppa-10-1421){ref-type="fig"}) in all measured domains of QoL (physical health, feelings, work, household, school, leisure time, and in general). These results are in agreement with the results of the other studies, where BPD strongly impairs the QoL in all areas.[@b22-ppa-10-1421],[@b24-ppa-10-1421],[@b96-ppa-10-1421] However, BPD patients included in our study were comorbid with anxiety disorders ([Table 2](#t2-ppa-10-1421){ref-type="table"}). Because of this comorbidity, it is hard to say to what extent the personality disorder itself influences the reduced QoL and to what extent the anxiety disorder influences. It was demonstrated that anxiety disorders affect the QoL.[@b97-ppa-10-1421] The question remains as to what is the influence of anxiety disorders and what is the impact of personality disorder itself on reduced QoL in borderline patients. The concrete personal impact on the QoL could be different.[@b43-ppa-10-1421],[@b96-ppa-10-1421],[@b97-ppa-10-1421] Moreover, it is hard to measure the proportion of impact for each entity. In the Czech Republic, patients are usually hospitalized because of their increased suicide risk or comorbid disorders but not for the BPD itself. However, the level of QoL and clinical variables in BPD patients were not influenced by the type of comorbid anxiety disorder ([Tables 3](#t3-ppa-10-1421){ref-type="table"} and [4](#t4-ppa-10-1421){ref-type="table"}). This may be related to the relatively low impact of anxiety disorders on QoL or correlated with the disability in work.

In line with expectations, when we look at the measurements of the intensity of psychopathology and its relationship with QoL, the overall QoL correlated with both subjCGI and objCGI, and with the level of depression measured by BDI. Whereas objCGI and SAS correlate with physical health, household, and leisure domains, the subjCGI correlates with physical health and household but not leisure domain. The level of depression exhibits the impact on all domains of Q-LES-Q. The severity of the disorder correlated with the QoL was also identified in other psychiatric diseases, like bipolar disorder and schizophrenia.[@b28-ppa-10-1421],[@b98-ppa-10-1421] Four domains out of seven correlated with the subjective level of anxiety. The difference may indicate a greater importance of the subjective perception of depressive symptoms than anxiety symptoms in the QoL in borderline patients. In contrast, another study[@b99-ppa-10-1421] showed anxiety and depressive symptoms to be identically associated with all domains of QoL in primary care patients.

Psychological dissociation assessed with the DES was not correlated with most domains of the QoL measured by Q-LES-Q, except the domain of leisure time ([Table 5](#t5-ppa-10-1421){ref-type="table"}). In previous studies, the authors have described a reduced QoL due to dissociation and PTSD, in traumatized individuals[@b100-ppa-10-1421],[@b101-ppa-10-1421] and sexually abused women.[@b102-ppa-10-1421] Dissociation protects individuals against the negative emotions but also prevents experiencing positive emotions, which are of particular importance for leisure. The more the patients dissociate, the lower the level of quality of leisure time they experience.

The antidepressant dosage negatively correlated with leisure time and QoL in general. Antidepressant medication and dissociation correlate with the QoL in a remarkably similar manner. The emotional detachment was described by the patients using antidepressants as one of the common side effects.[@b103-ppa-10-1421] In other words, antidepressants may produce symptoms similar to dissociation and reduce the quality of leisure domain.

All domains of QoL statistically significantly correlated with social life and family life when assessed by SDS. This means that people, who assessed their social life and family life as more handicapped, experience impaired QoL in all domains. It is interesting that it is not visible in the assessment of disability in work, where only two domains, physical health and QoL in general, statistically significantly negative correlated with.

Limitations of the study
------------------------

The present study had several limitations. The patients were mostly unemployed for a long time, which could influence the QoL in all domains. Also, the selection of difficult-to-treat BPD patients can affect the outcome of the study: the patients referred to inpatient treatment were individuals who were difficult to treat with high levels of comorbidity with other psychiatric disorders. Additionally, the percentage of the explained variance in the different models was modest. Another limitation was that subjective self-rating questionnaires were mostly used, with unknown reliability in this population.

Therefore, it was difficult to assume that these results could be generalized to BPD patients as a group. Future surveys should examine groups that include the outpatient BPD patients with a lower frequency of comorbidity. The QoL in this study was measured by the Q-LES-Q, which is not a QoL questionnaire specific to BPD. On the other hand, when a study compares patients and healthy controls, it is necessary to use the instrument appropriate for both groups. Future research should verify these questionnaires with clinician-rated instruments.

An additional limitation of the study was the relatively small sample size. Patients, in comparison with the controls, were medicated, and possible side-effects could explain part of the differences seen between patients with BPD and controls.

Conclusion
==========

BPD patients suffering from comorbid anxiety disorder have an impaired QoL compared to healthy controls in all measured domains (physical health, feelings, work, household, school, leisure time, and in general). Negative correlations of the Q-LES-Q domains with clinical scales (DES, BDI, BAI, SAS, CGI, and SDS) are noticeable. In future, longitudinal investigation is needed to focus on how psychopathological symptoms affect the subjective QoL and if the QoL could change during the therapy.
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###### 

Inclusion and exclusion criteria

  Inclusion criteria                                                                              Exclusion criteria
  ----------------------------------------------------------------------------------------------- ------------------------------------------------
  Diagnosis of emotionally unstable personality disorder -- borderline type according to ICD-10   Acute decompensation of severe somatic illness
  Male or female aged between 18 and 65 years                                                     History of bipolar affective disorder
  Completed informed consent                                                                      History of major depressive disorder
  History of schizophrenia                                                                        
  Mental retardation                                                                              
  Current suicidal behavior                                                                       

**Abbreviation:** ICD-10, International Classification of Diseases, Tenth Revision.

###### 

Demographic and clinical data of the patients and controls

  Variable                                                    Patients (n=92)      Controls (n=40)      Statistic
  ----------------------------------------------------------- -------------------- -------------------- -----------------------------------------------------
  Age (years)                                                 30.49±9.25           28.88±9.68           Mann--Whitney test; *U*=1,669; ns
  Sex (M:F)                                                   24:68                12:28                Fisher's exact test; ns
  Age of disease onset of the psychiatric treatment (years)   22.69±11.13                               
  Lifetime duration of treatment (years)                      7.83±7.20                                 
  Psychiatric heredity                                        42 (45.7%)                                
  Education                                                                                             Chi-square; ns
   Elementary                                                 13                   2                    
   Vocational training                                        21                   4                    
   Secondary school                                           46                   28                   
   University                                                 12                   6                    
  Marital status                                                                                        Chi-square; *P*\<0.0005
   Single                                                     64                   24                   
   Married                                                    12                   12                   
   Divorced                                                   15                   4                    
   Widowed                                                    1                    0                    
  objCGI severity                                             4.34±1.07                                 
  subjCGI severity                                            4.19±1.27                                 
  BAI                                                         26.41±11.12          7.88±7.41            Unpaired *t*-test: *t*=11.09, *df*=130; *P*\<0.0001
  BDI                                                         29.03±10.09          6.03±5.07            Unpaired *t*-test: *t*=11.93, *df*=130; *P*\<0.0001
  Q-LES-Q domains                                                                                       
   Physical health                                            29.45±9.73 (n=92)    42.53±11.47 (n=40)   Unpaired *t*-test: *t*=6.714, *df*=130; *P*\<0.0001
   Feelings                                                   30.48±9.61 (n=69)    44.70±5.91 (n=30)    Unpaired *t*-test: *t*=7.498, *df*=97; *P*\<0.0001
   Work                                                       42.22±10.88 (n=32)   55.12±6.72 (n=17)    Unpaired *t*-test: *t*=4.446, *df*=47; *P*\<0.0001
   Household                                                  33.8±8.75 (n=92)     55.18±8.43 (n=40)    Unpaired *t*-test: *t*=13.04, *df*=130; *P*\<0.0001
   School/study                                               27.50±6.52 (n=10)    35.83±7.81 (n=30)    Unpaired *t*-test: *t*=3.032, *df*=38; *P*\<0.005
   Leisure                                                    17.15±4.95 (n=92)    25.03±3.96 (n=40)    Unpaired *t*-test: *t*=8.899, *df*=130; *P*\<0.0001
   Social activities                                          20.10±9.90 (n=92)    45.53±7.49 (n=40)    Unpaired *t*-test: *t*=8.809, *df*=130; *P*\<0.0001
   General                                                    36.24±9.21 (n=92)    57.83±10.21 (n=40)   Unpaired *t*-test: *t*=11.97, *df*=130; *P*\<0.0001
  DES                                                         19.06±15.23                               
  DES-T                                                       13.55±17.38                               

**Note:** Data are presented as mean ± SD or n (%).

**Abbreviations:** ns, non-significant; M, male; F, female; objCGI, objective Clinical Global Impression; subjCGI, subjective Clinical Global Impression; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; Q-LES-Q, Quality of Life Satisfaction and Enjoyment Questionnaire; *df*, degrees of freedom; DES, Dissociative Experiences Scale; DES-T, Dissociative Experiences Scale Taxon; SD, standard deviation.

###### 

Comorbid disorders with borderline personality disorder on Axis I and II

  Types of comorbidity                                              Number of patients   Percentage of patients
  ----------------------------------------------------------------- -------------------- ------------------------
  Anxiety spectrum disorders                                                             
   Panic disorder/agoraphobia                                       17                   18.5
   Social phobia                                                    19                   20.7
   Generalized anxiety disorder/mixed anxiety depression disorder   16                   17.4
   Obsessive--compulsive disorder                                   5                    5.4
   Posttraumatic stress disorder                                    8                    8.7
   Adjustment disorder                                              21                   22.8
   Somatoform disorder/dissociative disorders                       6                    6.5
   Two or more comorbidities                                        18                   19.6
  Axis II comorbidities                                                                  
   Avoidant personality disorder                                    6                    6.5
   Mixed personality disorder                                       6                    6.5
   History of minor depressive disorder                             5                    5.4

**Note:** Data are presented as n and %.

###### 

Quality of life and comorbid diagnosis with different anxiety spectrum disorders

  Q-LES-Q domains     Panic disorder/agoraphobia (n=17)                       Social phobia (n=19)   GAD (n=16)   Adjustment disorders (n=21)   Others (n=19)
  ------------------- ------------------------------------------------------- ---------------------- ------------ ----------------------------- ---------------
  Physical health     26.9±8.5                                                29.9±11.4              29.6±6.5     30.7±9.8                      29.7±11.7
   Statistic          One-way analysis of variance: *F*=0.3693, *df*=91; ns                                                                     
  Feelings            33.3±7.5                                                28.6±11.4              35.9±10.5    29.4±9.5                      26.5±7.5
   Statistic          One-way analysis of variance: *F*=2.183, *df*=68; ns                                                                      
  Household           34.8±10.3                                               32.4±8.4               36.3±8.1     34.8±7.3                      31.2±9.5
   Statistic          One-way analysis of variance: *F*=1.013, *df*=91; ns                                                                      
  Leisure             18.2±5.0                                                16.4±5.2               19.7±3.7     16.5±4.9                      15.6±5.1
   Statistic          One-way analysis of variance: *F*=1.982, *df*=91; ns                                                                      
  Social activities   31.9±14.6                                               27.6±8.8               30.8±8.5     30.5±7.3                      29.9±10.0
   Statistic          One-way analysis of variance: *F*=0.4596, *df*=91; ns                                                                     
  General             35.2±9.1                                                37.4±10.7              36.5±10.1    37.0±7.4                      35.0±9.5
   Statistic          One-way analysis of variance: *F*=0.2446, *df*=91; ns                                                                     

**Note:** Data are presented as mean ± SD.

**Abbreviations:** Q-LES-Q, Quality of Life Satisfaction and Enjoyment Questionnaire; GAD, generalized anxiety disorder; *df*, degrees of freedom; ns, nonsignificant; SD, standard deviation.

###### 

Comorbidity and clinical measurements

                    Panic disorder/agoraphobia (n=17)                                                                                                                                  Social phobia (n=19)   GAD (n=16)    Adjustment disorders (n=21)   Others (n=19)
  ----------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------- ------------- ----------------------------- ---------------
  DES               19.45±16.66                                                                                                                                                        14.01±12.01            18.53±14.24   19.65±14.82                   23.59±17.84
   Statistic        One-way analysis of variance: *F*=0.9563, *df*=90; ns                                                                                                                                                                                 
  DES-T             15.60±18.78                                                                                                                                                        8.07±10.80             10.04±13.81   12.56±13.42                   21.17±24.90
   Statistic        One-way analysis of variance: *F*=1.675, *df*=90; ns                                                                                                                                                                                  
  BDI               27.06±9.01                                                                                                                                                         26.74±10.71            29.38±9.19    30.52±9.56                    31.16±11.79
   Statistic        One-way analysis of variance: *F*=0.5738, *df*=91; ns                                                                                                                                                                                 
  BAI               32.82±12.51                                                                                                                                                        22.42±8.19             24.75±10.69   25.00±10.71                   27.63±11.59
   Statistic        One-way analysis of variance: *F*=2.394, *df*=91; ns (*P*=0.0566); Bonferroni's multiple comparison test: panic disorder/agoraphobia vs social phobia, *P*\<0.05                                                                      
  SAS               71.06±19.82                                                                                                                                                        58.89±21.53            58.38±20.29   58.30±18.44                   64.68±25.75
   Statistic        One-way analysis of variance: *F*=1.205, *df*=90; ns                                                                                                                                                                                  
  objCGI-S          4.77±0.90                                                                                                                                                          4.05±1.27              4.19±1.05     4.19±0.93                     4.53±1.12
   Statistic        One-way analysis of variance: *F*=1.356, *df*=91; ns                                                                                                                                                                                  
  subjCGI-S         4.41±1.06                                                                                                                                                          4.42±1.12              4.13±1.15     3.76±1.48                     4.42±1.31
   Statistic        One-way analysis of variance: *F*=1.082, *df*=91; ns                                                                                                                                                                                  
  SDS-work/school   6.80±2.66                                                                                                                                                          7.54±1.61              6.55±2.81     5.57±2.62                     6.81±3.04
   Statistic        One-way analysis of variance: *F*=1.003, *df*=63; ns                                                                                                                                                                                  
  SDS-social life   6.65±1.54                                                                                                                                                          7.26±2.28              6.13±1.82     6.00±2.56                     6.42±3.01
   Statistic        One-way analysis of variance: *F*=0.8637, *df*=90; ns                                                                                                                                                                                 
  SDS-family        5.88±2.09                                                                                                                                                          5.68±2.36              5.19±3.02     5.55±2.59                     7.05±2.84
   Statistic        One-way analysis of variance: *F*=1.365, *df*=90; ns                                                                                                                                                                                  

**Note:** Data are presented as mean ± SD.

**Abbreviations:** GAD, generalized anxiety disorder; DES, Dissociative Experiences Scale; DES-T, Dissociative Experiences Scale Taxon; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; SAS, Sheehan Anxiety Scale; objCGI, objective Clinical Global Impression; subjCGI, subjective Clinical Global Impression; SDS, Sheehan Disability Scale; *df*, degrees of freedom; ns, nonsignificant; SD, standard deviation.

###### 

Correlations of the Q-LES -Q results with demographic and clinical data

  Variable                 Physical health                                                                                         Feelings                                                                                              Work                                                                                                  Household                                                                                               Leisure                                                                                                 Social activities                                                                                       General
  ------------------------ ------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------
  Age                      −0.1553[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     0.2148[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                    0.1342[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                    0.0846[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      0.0137[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      −0.0885[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.0812[a](#tfn10-ppa-10-1421){ref-type="table-fn"}
  Age of disorder onset    −0.2093[a](#tfn10-ppa-10-1421){ref-type="table-fn"}[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}        0.098[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     0.2741[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                    0.0689[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      −0.0121[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     0.0014[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      −0.0152[a](#tfn10-ppa-10-1421){ref-type="table-fn"}
  Length of the disorder   0.0947[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      0.1371[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                    −0.2497[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   −0.0238[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     0.0340[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      −0.1101[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.0811[a](#tfn10-ppa-10-1421){ref-type="table-fn"}
  DES                      −0.1110[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.1047[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                   −0.0721[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                   −0.1287[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.2240[b](#tfn11-ppa-10-1421){ref-type="table-fn"},[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}       −0.0441[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.0803[b](#tfn11-ppa-10-1421){ref-type="table-fn"}
  DES-T                    −0.1249[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.1883[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                   −0.1558[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                   −0.1549[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.2394[b](#tfn11-ppa-10-1421){ref-type="table-fn"},[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}       −0.1342[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.1928[b](#tfn11-ppa-10-1421){ref-type="table-fn"}
  BDI                      −0.4166[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.3779[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}   −0.5493[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}   −0.6680[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.4721[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.5214[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.6336[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  BAI                      −0.3629[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.0403[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   0.0603[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                    −0.2951[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}     −0.2085[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}       0.0122[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                      −0.3506[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  SAS                      −0.3935[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.1719[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   −0.2251[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   −0.4420[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.3623[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}   −0.1577[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.4642[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  objCGI-S                 −0.4119[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.1021                                                                                               −0.1458                                                                                               −0.5725[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.3927[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.3415[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.5498[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  subjCGI-S                −0.2920[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}      −0.0665                                                                                               −0.0479                                                                                               −0.2930[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}      −0.1482                                                                                                 −0.2726[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}        −0.3676[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  SDS-work                 −0.3547[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.058[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                    −0.2882[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                   −0.2357[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.2381[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}       −0.1636[b](#tfn11-ppa-10-1421){ref-type="table-fn"}                                                     −0.1778[b](#tfn11-ppa-10-1421){ref-type="table-fn"}
  SDS-social life          −0.3437[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.3601[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}    −0.5414[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}    −0.5355[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.5257[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.5667[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.5506[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  SDS-family               −0.3715[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.3650[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}    −0.4659[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*](#tfn13-ppa-10-1421){ref-type="table-fn"}    −0.5284[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.5163[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.4798[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}    −0.5519[b](#tfn11-ppa-10-1421){ref-type="table-fn"}[\*\*\*](#tfn14-ppa-10-1421){ref-type="table-fn"}
  Antidepressants (n=63)   −0.1820[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.0177[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   −0.0818[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   −0.2101[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.2733[a](#tfn10-ppa-10-1421){ref-type="table-fn"},[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}       −0.2300[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.2347[a](#tfn10-ppa-10-1421){ref-type="table-fn"}[\*](#tfn12-ppa-10-1421){ref-type="table-fn"}
  Antipsychotics (n=35)    −0.2328[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.2694[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   0.1127[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                    −0.1288[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.3202[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.2702[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.2389[a](#tfn10-ppa-10-1421){ref-type="table-fn"}
  Anxiolytics (n=28)       0.2289                                                                                                  0.2130                                                                                                −0.0634[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                   −0.2339[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.0031[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.0166[a](#tfn10-ppa-10-1421){ref-type="table-fn"}                                                     −0.2496[a](#tfn10-ppa-10-1421){ref-type="table-fn"}

**Notes:** Data are presented as mean ± SD.

Pearson.

Spearman.

*P*\<0.05.

*P*\<0.01.

*P*\<0.001.

**Abbreviations:** Q-LES-Q, Quality of Life Satisfaction and Enjoyment Questionnaire; DES, Dissociative Experiences Scale; DES-T, Dissociative Experiences Scale Taxon; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; S, severity; SAS, Sheehan Anxiety Scale; objCGI, objective Clinical Global Impression; subjCGI, subjective Clinical Global Impression; SDS, Sheehan Disability Scale; SD, standard deviation.

###### 

Backward stepwise regression of the factors correlated with Q-LES-Q domains

                                                             Domain (dependent variables)                                                                                                                                                                                                                                                                                                                                              
  ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------ -----
  Significant correlation with (independent variables)       Onset                                                      BDI                                                        BDI                                                          BDI                                                          DES                                                          BDI                                                          BDI
  BAI                                                        SDS-family                                                 SDS-social                                                 SDS-family                                                   BAI                                                          SDS-social                                                   SDS-social                                                   
  BDI                                                        SDS-social                                                 SDS-family                                                 SDS-social                                                   BDI                                                          SDS-family                                                   SDS-family                                                   
  SAS                                                                                                                                                                              BAI                                                          SAS                                                                                                                       AD dosage                                                    
  objCGI                                                                                                                                                                           SAS                                                          objCGI                                                                                                                                                                                 
  SDS-work                                                                                                                                                                         objCGI                                                       SDS-work                                                                                                                                                                               
  SDS-social                                                                                                                                                                                                                                    SDS-social                                                                                                                                                                             
  SDS-family                                                                                                                                                                                                                                    SDS-family                                                                                                                                                                             
                                                                                                                                                                                                                                                AD dosage                                                                                                                                                                              
  Number of steps Adjusted *r*^2^ Variables                  5                                                          2                                                          3                                                            4                                                            8                                                            2                                                            3
  0.301                                                      0.227                                                      0.267                                                      0.533                                                        0.495                                                        0.340                                                        0.510                                                        
  Onset:                                                     BDI:                                                       BDI:                                                       BDI:                                                         DES:                                                         SDS-social:                                                  SDS-social:                                                  
  *β*=−0.256,                                                *β*=−0.226,                                                *β*=−0.539,                                                *β*=−0.493,                                                  *β*=−0.230,                                                  *β*=−0.322,                                                  *β*=−0.429,                                                  
  *P*=0.018[\*](#tfn17-ppa-10-1421){ref-type="table-fn"}     *P*=0.056                                                  *P*=0.002[\*\*](#tfn18-ppa-10-1421){ref-type="table-fn"}   *P*=0.000[\*\*\*](#tfn19-ppa-10-1421){ref-type="table-fn"}   *P*=0.033[\*](#tfn17-ppa-10-1421){ref-type="table-fn"}       *P*=0.001[\*\*\*](#tfn19-ppa-10-1421){ref-type="table-fn"}   *P*=0.000[\*\*\*](#tfn19-ppa-10-1421){ref-type="table-fn"}   
  BAI:                                                       SDS-family:                                                                                                           SDS-family:                                                  SDS-social:                                                  BDI: *β*=−0.386,                                             BDI:                                                         
  *β*=−0.200,                                                *β*=−0.368,                                                                                                           *β*=−0.176,                                                  *β*=−0.635,                                                  *P*=0.000[\*\*\*](#tfn19-ppa-10-1421){ref-type="table-fn"}   *β*=−0.395,                                                  
  *P*=0.088                                                  *P*=0.002[\*\*](#tfn18-ppa-10-1421){ref-type="table-fn"}                                                              *P*=0.045[\*](#tfn17-ppa-10-1421){ref-type="table-fn"}       *P*=0.000[\*\*\*](#tfn19-ppa-10-1421){ref-type="table-fn"}                                                                *P*=0.000[\*\*\*](#tfn19-ppa-10-1421){ref-type="table-fn"}   
  BDI:                                                                                                                                                                             SDS-social:                                                                                                                                                                                                                                         
  *β*=−0.332,                                                                                                                                                                      *β*=−0.242,                                                                                                                                                                                                                                         
  *P*=0.005[\*\*](#tfn18-ppa-10-1421){ref-type="table-fn"}                                                                                                                         *P*=0.006[\*\*](#tfn18-ppa-10-1421){ref-type="table-fn"}                                                                                                                                                                                            
  SDS-work:                                                                                                                                                                                                                                                                                                                                                                                                                            
  *β*=−0.265,                                                                                                                                                                                                                                                                                                                                                                                                                          
  *P*=0.015[\*](#tfn17-ppa-10-1421){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                               

**Notes:** *β* is the standardized coefficient.

*P*\<0.01;

*P*\<0.01;

*P*\<0.001.

**Abbreviations:** Q-LES-Q, Quality of Life Satisfaction and Enjoyment Questionnaire; BDI, Beck Depression Inventory; DES, Dissociative Experiences Scale; BAI, Beck Anxiety Inventory; SDS, Sheehan Disability Scale; SAS, Sheehan Anxiety Scale; AD, antidepressant; objCGI, objective Clinical Global Impression.
